Pharmacy Podcast Network cover art

Pharmacy Podcast Network

Pharmacy Podcast Network

Written by: Pharmacy Podcast Network
Listen for free

About this listen

Pharmacy Podcast Network (PPN) is the world’s largest network of podcasts dedicated to the pharmacy professional and industry insiders. Our content is about dynamic people in the pharmacy industry making a difference and delivering the best pharmacy care. We have over 40+ podcasts with thousands of interviews.

Pharmacists are the cornerstone of healthcare, and the PPN reflects that. From Community, LTC, Specialty Pharmacy to Drug Development, Government policy and DigitalHealth, we cover it all. Partner with us to connect with thousands of daily listeners and find the right pharmacist across various specialties and topics, ensuring your products and services resonate where it matters most. We build strong audio brands through Pharmacists who see patients almost 9x more than primary care.

Join the home of the O.G. Pharmacy Podcast & discover our newest development: Evidence-based Podcasting, the first CME supplement in podcast form that's truly peer-reviewed. The future of podcasting education for Providers is "Evidence-based Podcasting" (TM) and we're building a peer-review board, reach out to us: Publisher @ Pharmacy Podcast dot com.


PPN is a division of RxPR, LLC. Copyright 2026

2026 Pharmacy Podcast Network (TM)
Hygiene & Healthy Living Physical Illness & Disease Politics & Government
Episodes
  • The Three Biggest Healthcare News of 2025| RxRated Podcast
    Jan 12 2026

    In this episode of the Rated Rx Podcast, pharmacists break down the biggest healthcare news of 2025 and what it actually means for patients and clinicians 👀💊. You hear real pharmacist perspectives on artificial intelligence in healthcare, new federal plans to regulate AI, and why clinical judgment, patient trust, and human decision making still matter more than algorithms 🤖➡️🧠. The conversation also dives into major vaccine policy changes, including updates to newborn hepatitis B vaccination recommendations and why shifts like this raise real concerns for public health 🧬🩺. The crew explains what these changes mean in practice, how misinformation spreads fast, and why prevention still saves lives. Later, the episode tackles the explosion of GLP 1 weight loss medications like semaglutide and tirzepatide. You hear honest discussion about access, cost, compounding risks, and why obesity needs to be treated as a chronic disease instead of a personal failure ⚖️📈. This episode blends news, clinical insight, and real world experience to unpack where healthcare is heading next. This podcast is intended for entertainment and informational purposes only. Listen and Follow Rated Rx 🎙️ Apple Podcasts https://podcasts.apple.com/us/podcast/the-rated-rx-podcast/id1804181016 Spotify https://open.spotify.com/show/7KATtG1c3HwwYpVMtRuNub Facebook https://www.facebook.com/profile.php?id=61574813907982 Instagram https://www.instagram.com/ratedrxpodcast/ TikTok https://www.tiktok.com/@ratedrxpodcast

    Show More Show Less
    43 mins
  • The Season to Innovate: Strategic Legal and Regulatory Considerations for Approaching Acquisitions and Vetting AI Vendors | NASP Specialty Pharmacy Podcast
    Jan 9 2026
    In this episode of the NASP Podcast, Sheila Arquette, President & CEO of NASP, speaks with Simone Colgan Dunlap, National Vice Chair of the Quarles Health and Life Sciences Practice Group, and Amy Cotton Peterson, Partner at Quarles. As more automation solutions become available, its vital specialty pharmacy providers strategically approach acquisition of targets that offer technology and AI assets. This discussion explores effective diligence practices, common pitfalls, and risk mitigation strategies for specialty pharmacies navigating mergers and acquisitions and the rapidly evolving use of artificial intelligence.
    Show More Show Less
    22 mins
  • Doing Things Differently: YARAL Pharma, Pennsylvania Policy, and the Birth Control Pharmacist | TWIRx
    Jan 9 2026
    🎙️ This Week in Pharmacy (TWIRx) — January 9, 2026 Welcome to TWIRx — This Week in Pharmacy! I’m your host Todd Eury, and today’s episode is sponsored by YARAL Pharma, a generics company committed to “Doing Things Differently”—with a human-centered, untraditional approach that’s redefining relationships between industry and pharmacy practice. ✅ Today’s Sponsor: YARAL Pharma YARAL Pharma is committed to innovation, partnership, and supporting pharmacists at the front lines—especially as healthcare continues to restructure and the role of the pharmacist becomes more essential than ever. Their mission to Do Things Differently is more than a slogan—it’s a commitment to reshaping what a generics company can stand for in today’s healthcare marketplace. 📰 This Week in Pharmacy — News 1) Amazon Pharmacy to Offer Novo Nordisk’s Wegovy Pill Nationwide Amazon Pharmacy is now offering Novo Nordisk’s newly FDA-approved Wegovy pill, making the weight-loss medication available nationwide through both insurance coverage and cash-pay options. This move continues Amazon’s expansion into digital healthcare access—bringing blockbuster GLP-1 therapies directly to consumers and increasing competition among major pharmacy providers. https://www.mobihealthnews.com/news/amazon-pharmacy-offer-novo-nordisks-wegovy-pill 2) Dr. David Pope: AI, Online Pharmacies, and Why the Neighborhood Pharmacist Still Wins Trust In a must-read guest column, Dr. David Pope argues that while AI and online pharmacy services are rapidly surging, the community pharmacist remains one of the most trusted healthcare professionals in America. He points to how pharmacy deserts, increasing reimbursement pressure, and policy reform will reshape pharmacy in 2026—and why the profession’s future will depend on protecting and empowering local pharmacy care. https://drugstorenews.com/ai-and-online-pharmacy-surge-neighborhood-pharmacist-remains-most-trusted 3) Pharmacist Leadership Spotlight: Illuminate Rx Names Ritu Malhotra, PharmD, as President Illuminate Rx announced the appointment of Ritu Malhotra, PharmD, as its new President, reinforcing the growing trend of pharmacists stepping into leadership roles across pharmacy benefits and PBM reform. With decades of experience modernizing healthcare and pharmacy benefit strategy, Malhotra’s appointment signals Illuminate Rx’s focus on improving transparency and clarity in pharmacy benefits management. https://www.prnewswire.com/news-releases/illuminate-rx-appoints-industry-veteran-ritu-malhotra-pharmd-as-president-to-advance-clarity-in-pharmacy-benefits-302657441.html 4) Viatris Exec David Marin Named New CEO of PCMA The Pharmaceutical Care Management Association (PCMA)—the leading PBM trade group—has named David Marin, previously Head of Global Government Affairs & Public Policy at Viatris, as its next President and CEO effective January 30, 2026. His selection comes at a pivotal time as PBMs face rising scrutiny and intensifying policy pressure nationwide. https://www.healthcaredive.com/news/pcma-names-new-ceo-david-marin/809158/ 🎤 Interviews & Segments ⭐ Segment 1 — Special Sponsor Interview Stephen Beckman, CEO of YARAL Pharma We kick off TWIRx with a special conversation featuring Stephen Beckman, CEO of YARAL Pharma, exploring what 2026 has in store for pharmacy and healthcare. We discuss the Pharmacy 50 Awards, the importance of honoring leadership across the profession, and why supporting pharmacists right now—during one of the most fragile and transformative moments in U.S. healthcare—is absolutely critical. ⭐ Featured Interview — Pennsylvania State Representative Rep. Charity Grimm Krupa — 51st Legislative District Today’s featured interview is with State Representative Charity Grimm Krupa, who represents Pennsylvania’s 51st Legislative District in the House of Representatives. We discuss real healthcare issues impacting Pennsylvanians—including medical cannabis, small business healthcare benefit strategies, and why it’s essential for healthcare professionals to stay connected with their state lawmakers. Rep. Krupa also shares why every citizen should aim to communicate with their own representatives at least once per year. ⭐ Segment 2 — Clinical & Policy Spotlight Dr. Sally Rafie, PharmD — “The Birth Control Pharmacist” In our second segment, we welcome Dr. Sally Rafie, PharmD, nationally known as the “Birth Control Pharmacist.” Dr. Rafie is a clinical pharmacist specialist at UC San Diego Health and an assistant clinical professor at the UC San Diego Skaggs School of Pharmacy, widely recognized for advancing pharmacists’ role in reproductive health care. She is also the founder of Birth Control Pharmacist, an education and training company that equips pharmacists and healthcare teams to prescribe and deliver contraception care through evidence-based ...
    Show More Show Less
    1 hr and 37 mins
No reviews yet